Correlation between mpMRI-detected lesions and definite neoplastic foci at radical prostatectomy: Level of agreement in terms of size and proximity to the capsule

Correlation between mpMRI-detected lesions and definite neoplastic foci at radical prostatectomy: Level of agreement in terms of size and proximity to the capsule

Bibliographic Details
Main Authors:	E. Morini, L. Marzotta, M.C. Sighinolfi, B. Filippi, C. Del Prete, A. Iseppi, A. Eissa, B. Reggiani, M. Rizzo, P. Torricelli, M. Sandri, M. Paterlini, S. Micali, G. Bianchi, B. Rocco
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320300446

Similar Items

Which is the value of a negative mpMRI in ruling out adverse pathological outcomes at radical prostatectomy?: A retrospective analysis on 212 prostatic lobes
by: S. Ciarlariello, et al.
Published: (2020-01-01)

Multiparametric magnetic resonance imaging (mpMRI): Which variable better predicts extracapsular extension of prostate cancer?
by: M.C. Sighinolfi, et al.
Published: (2020-01-01)

Analisys of contralateral prostatic cancer odds in patients with monolateral lesions at mpMRI
by: A. Iseppi, et al.
Published: (2020-01-01)

Comparison between biparametric prostate MRI (bpMRI) and multiparametric MRI (mpMRI) in the detection of prostate cancer
by: A. Iseppi, et al.
Published: (2020-01-01)

Assessing the value of mpMRI PIRADS lesions in the transitional zone: Analysis of a single center repeat biopsy cohort
by: L. Sarchi, et al.
Published: (2020-01-01)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

Added value of risk calculators to mpMRI in the diagnosis of prostate cancer
by: J.R. Gonçalves Correia, et al.
Published: (2020-07-01)

Biomarker accompanied significance of mpMRI-visible and invisible lesions for adverse pathology and biochemical recurrence after radical prostatectomy
by: J. Eineluoto, et al.
Published: (2020-07-01)

Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
by: Michael E. Rezaee, et al.
Published: (2020-09-01)

Which men should undergo non-targeted systematic sampling in an mpMRI-targeted pathway – an analysis from 1,719 pre-biopsy mpMRI cases?
by: M.J. Connor, et al.
Published: (2020-07-01)

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS
by: J. Norris, et al.
Published: (2020-07-01)

Accuracy of mpMRI in detecting lesion location in prostate cancer-inital experience
by: M. Parameswaran, et al.
Published: (2020-11-01)

Correlation between Gleason score and PIRADS score on mpMRI –initial experience
by: M. Parameswaran, et al.
Published: (2020-11-01)

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
by: Michelle D. Bardis, et al.
Published: (2020-05-01)

Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
by: G. Wei, et al.
Published: (2021-05-01)

Indeterminate mpMRI lesions: Evaluating the optimal PSA density threshold for prostate biopsy
by: D.T. Reddy, et al.
Published: (2020-07-01)

Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information
by: Chao Han, et al.
Published: (2021-06-01)

mpMRI-visible prostate cancer is enriched with genomic hallmarks of poor prognosis: A bioinformatic analysis
by: J. Norris, et al.
Published: (2020-07-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI- fusion biopsie
by: D. Maffei, et al.
Published: (2020-11-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Intraoperative assessment of peri-prostatic tissue with fluorescence confocal microscopy: A novel method to tailor surgical dissection during radical prostatectomy
by: B.M.C. Rocco, et al.
Published: (2020-01-01)

Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath trial
by: R.T. Bryan, et al.
Published: (2020-07-01)

Anatomical prostate mpMRI features and continence recovery after robot assisted radical prostatectomy: is there something beyond membranous urethral length? results from a large, multi-institutional cohort
by: M. Tutolo, et al.
Published: (2020-10-01)

Nomogram including maximum core length at biopsy and index lesion size at mpMRI best predicts the extra-capsular extension of prostate cancer at whole-mount sections of radical prostatectomies
by: F. Sanguedolce, et al.
Published: (2020-07-01)

Radiomic analysis of T2 and ADC mpMRI images in the diagnosis of clinical significant prostate cancer: An early experience
by: F. Prata, et al.
Published: (2020-07-01)

Anatomical prostate mpMRI features and continence recovery after robot assisted radical prostatectomy: is there something beyond membranous urethral length? results from a large, multi-institutional cohort
by: M. Tutolo, et al.
Published: (2020-10-01)

Radiomic analysis of T2 and ADC mpMRI images in the diagnosis of clinical significant prostate cancer: An early experience
by: F. Prata, et al.
Published: (2020-10-01)

The RAPID risk model: A novel risk score to predict significant prostate cancer in men with an mpMRI lesion
by: D. Eldred-Evans, et al.
Published: (2020-07-01)

Added value of quantitative DCE imaging on mpMRI prediction of stage ≥pT3 prostate cancer
by: R. Girometti, et al.
Published: (2020-07-01)

Evaluation of the PI-RADS Scoring System for Classifying mpMRI Findings in Men with Suspicion of Prostate Cancer
by: Daniel Junker, et al.
Published: (2013-01-01)

Evaluation of PSA density for the detection of clinically significant prostate cancer in biopsy-naive patients with PI-RADS 3 lesions
by: A. Iseppi, et al.
Published: (2020-10-01)

Prostate “Mapeo” for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy.
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-01-01)

Transperineal free-hand mpMRI targeted prostate biopsies under local anesthesia: A preliminary analysis of learning curves
by: G. Calleris, et al.
Published: (2020-07-01)

Does the number of nodes removed at the pelvic lymphadenectomy impact on cancer specific survival of pca patients with adverse pathological outcomes at radical prostatectomy? A retrospective 5- and 10-years analysis on 1274 series
by: E. Morini, et al.
Published: (2020-01-01)

Oncotype DX genomic prostate score and final tumor pathology: A new instrument in pre-radical prostatectomy counseling
by: B. Filippi, et al.
Published: (2020-10-01)

Prostate mpMRI and MRI-Targeted Biopsy: State-of-the-art Protocol + PI-RADS v2.1
by: Pieter De Visschere, et al.
Published: (2019-11-01)

Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI
by: E. J. Her, et al.
Published: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-07-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-11-01)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
by: Abraham M. Getaneh, et al.
Published: (2021-01-01)